建科股份(301115.SZ):擬7750萬元收購冠標檢測55%股權
格隆匯10月12日丨建科股份(301115.SZ)公佈,公司擬以部分超募資金7,750萬元(收購總價為8,250萬元,扣除前期以自有資金支付的定金500萬元後為7,750萬元,簽訂正式協議後定金轉為股權轉讓款。)收購冠標(上海)檢測技術有限公司(以下簡稱"冠標檢測")55%股權,交易完成後,冠標檢測將成為公司控股子公司,納入公司合併報表範圍。
據瞭解,本次交易標的冠標檢測是一家獨立的第三方檢測機構,主要提供汽車及其零部件、電子電器等相關檢測服務。經過多年發展,冠標檢測在設備配置、技術儲備、測試能力等方面均達到行業領先水平,併為上汽通用、上汽大眾、奇瑞捷豹路虎、上汽商用車、北汽乘用車、菲亞特克萊斯勒、沃爾沃等多所大型汽車生產廠和研發中心提供長期的檢測服務及技術支持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.